SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
This Quarter Return
+63.6%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$171M
AUM Growth
+$171M
Cap. Flow
-$66.3M
Cap. Flow %
-38.78%
Top 10 Hldgs %
71.58%
Holding
38
New
13
Increased
7
Reduced
9
Closed
7

Top Buys

1
BDSI
BioDelivery Sciences International, Inc.
BDSI
$7.91M
2
MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
$7.53M
3
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.67M
4
OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$3.32M
5
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3.16M

Top Sells

1
AMRN
Amarin Corp
AMRN
$67.8M
2
BSTC
BioSpecifics Technologies Corp.
BSTC
$10.3M
3
VNDA icon
Vanda Pharmaceuticals
VNDA
$6.32M
4
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$5.83M
5
RIGL icon
Rigel Pharmaceuticals
RIGL
$4.23M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NEOS
26
DELISTED
Neos Therapeutics, Inc
NEOS
$1.11M 0.65%
+227,919
New +$1.11M
FSTX
27
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$856K 0.5%
+71,050
New +$856K
VYNT
28
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$639K 0.37%
614,411
-777,196
-56% -$808K
SCYX icon
29
SCYNEXIS
SCYX
$34.9M
$539K 0.32%
+448,777
New +$539K
SRTS icon
30
Sensus Healthcare
SRTS
$55.7M
$317K 0.19%
+37,858
New +$317K
DOVA
31
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$145K 0.08%
+6,900
New +$145K
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$4.38B
– –
-194,900
Closed -$2.98M
ADMA icon
33
ADMA Biologics
ADMA
$4.12B
– –
-831,731
Closed -$3.75M
RIGL icon
34
Rigel Pharmaceuticals
RIGL
$697M
– –
-1,496,590
Closed -$4.23M
SNDX icon
35
Syndax Pharmaceuticals
SNDX
$1.41B
– –
-198,373
Closed -$1.39M
MTVA
36
MetaVia Inc. Common Stock
MTVA
$15.3M
– –
-103,000
Closed -$1.05M
CFMS
37
DELISTED
Conformis, Inc. Common Stock
CFMS
– –
-616,109
Closed -$770K
NVIV
38
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
– –
-77,900
Closed -$132K
1
2